Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards Phoenix S&T $1.2M Grant to Develop Protein Separation Device

NEW YORK (GenomeWeb News) – The National Institutes of Health has awarded Phoenix S&T a Phase II Small Business Innovation Research grant to develop a prototype microfluidics device to separate glycoproteins that may be used as biomarkers for cancer and other diseases, the company said last week.
Phoenix S&T said the award is worth as much as $1.2 million over three years.
The company, based in Elkton, Md., said it will use the funds to continue developing a microfluidic chromatographic device that uses nanoparticles as a medium for quickly separating complex proteins. The device will interface with nanospray mass spectrometry to detect and identify proteins, Phoenix S&T added.    
Company president Sau Lan Staats said Phoenix S&T's goal is to make the separation of post-translationally modified proteins "routine and high throughput," which is expected to increase efficiency in many applications.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.